next‑gen prostate biomarkers
Prostate Cancer Testing Will Change by 2026
In 2025 clinicians began using a new biomarker test that improves early prostate cancer detection, turning routine checkups into decisive early wins. This test examines tiny RNA fragments in blood, giving doctors a clearer picture of cancer risk without relying solely on PSA numbers. Medical Disclaimer: This article is for